The monomeric {Fe(NO)2}10 dinitrosyliron complexes (DNICs) [K‐18‐crown‐6‐ether][(NO)2Fe(NC9H6‐NH)] (1), [K‐18‐crown‐6‐ether][(NO)2Fe(NC9H6‐O)] (2), and [K‐18‐crown‐6‐ether][(NO)2Fe(NC9H6‐S)] (3) containing [N,NH], [N,O], and [N,S] ligations were synthesized by displacing the N,N,N′,N′‐tetramethylethylenediamine (tmeda) group of {Fe(NO)2}10 (tmeda)Fe(NO)2 with quinolin‐8‐amide, quinolin‐8‐olate, and quinolin‐8‐thiolate, respectively. Anionic {Fe(NO)2}10 DNICs 1–3 were characterized by IR, 1H NMR, and UV/Vis spectroscopy and single‐crystal X‐ray diffraction. The binding affinity of the ligands (i.e., [NC9H6NH]–, [NC9H6O]–, and [NC9H6S]–) toward the {Fe(NO)2}10 fragment was also investigated, and ligand substitution was found to follow the order [NC9H6S]– > [NC9H6O]– > [NC9H6NH]–. Displacement of the tmeda group of (tmeda)Fe(NO)2 by [K‐18‐crown‐6‐ether][SC6H4‐o‐NH2] and [PPh4][SC6H4‐o‐NH2] afforded monomeric {Fe(NO)2}10 DNIC [K‐18‐crown‐6‐ether][(NO)2Fe(SC6H4‐o‐NH2)] (4) and dimeric {Fe(NO)2}10–{Fe(NO)2}10 DNIC [PPh4]2[(NO)2Fe(μ‐SC6H4‐o‐NH2)]2 (5), respectively. The function of the countercation in the formation of monomeric {Fe(NO)2}10 DNIC 4 or dimeric {Fe(NO)2}10–{Fe(NO)2}10 DNIC 5 was also demonstrated upon reduction of the {Fe(NO)2}9 DNICs [cation][(NO)2Fe(SC6H4‐o‐NH2)2] (6) {cation = K‐18‐crown‐6‐ether (6a), [PPh4] (6b)}. In contrast to the formation of thiolate‐containing {Fe(NO)2}9 DNICs through nucleophilic cleavage of the bridging thiolates of Roussin's red esters, the transformation of complexes 4 and 5 into complexes 6a and 6b, respectively, in the presence of disulfide provides a new synthetic pathway for the synthesis of thiolate‐containing {Fe(NO)2}9 DNICs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.